Literature DB >> 21647953

Stroke in a young patient treated by alteplase heralding an acquired thrombotic thrombocytopenic purpura.

Amandine Sevy1, Emilie Doche, Christian Squarcioni, Pascale Poullin, Jacques Serratrice, Francois Nicoli, Pierre-Jean Weiller.   

Abstract

BACKGROUND AND
PURPOSE: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening multisystem disorder characterized by thrombocytopenia and fluctuating neurological symptoms due to microinfarcts. In rare cases, large cerebral arteries can be occluded. SUMMARY OF THE CASE: We report on a 30-year-old woman with a first-ever acute stroke related to a right proximal MCA M1 occlusion. Platelet count was normal at admission and progressively decreased 6 days after intravenous thrombolysis with the occurrence of a hemolytic anemia with schistocytes. Most biological anomalies reversed after plasma exchange. No hemorrhagic complication occurred. Diagnosis of initial TTP was confirmed by low ADAMTS13 activity and positivity of anti-ADAMTS13 antibody.
CONCLUSION: This observation highlights the fact that even if platelet count and hemoglobin rate are normal in the beginning, an acute ischemic stroke in a young patient can be related to TTP. Faced with subsequent thrombopenia, practitioners should be aware of acquired TTP, and, thus, schistocytes, haptoglobin, and LDH assays should be performed. Early diagnosis is paramount to start the life-saving plasma exchanges.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21647953     DOI: 10.1002/jca.20276

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  6 in total

1.  Pearls and oy-sters: acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura.

Authors:  Julio C Rojas; Chirantan Banerjee; Fazeel Siddiqui; Bardia Nourbakhsh; Craig M Powell
Journal:  Neurology       Date:  2013-05-28       Impact factor: 9.910

Review 2.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2017-08-02       Impact factor: 22.113

Review 3.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

4.  What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

5.  Stroke due to typical thrombotic thrombocytopenic purpura treated successfully with intravenous thrombolysis and therapeutic plasma exchange.

Authors:  Matteo Boattini; Gaetano Procaccianti
Journal:  BMJ Case Rep       Date:  2013-01-28

Review 6.  Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis'.

Authors:  Peter Kraft; Simon F De Meyer; Christoph Kleinschnitz
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-18       Impact factor: 6.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.